Greenrose Acquisition Corp.
Status: Deal Closed
U=S+W
W=S@11.5
| IPO Proceeds, $M | $172.50M |
|---|---|
| IPO Date | Feb 11, 2020 |
| CEO | William Harley III |
| Left Lead | Imperial Capital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 18+(1*3) |
| IPO Sector | Cannabis |
| IPO Geography | Global |
| Target Company | Shango Holdings, Futureworks, Theraplant and True Harvest |
| Deal Announced | Mar 15, 2021 |
| Deal Size, $M | $296.40M |
| Deal Sector | Cannabis |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Oct 27, 2021 |
| Amendment Vote | TBD |
| Closing Date | Nov 29, 2021 |
Formerly GNRS
GNRS
GNRSW
| Price | $0.00 |
|---|---|
| Last closing price | $0.00 |
| H/L, 52-week | $0.00 / $1.08 |
| Volume, today | 70 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Greenrose Acquisition Corp.:
- Structure and cap table
- 9 directors & officers
- 32 filings and events
- 2 underwriters
- 2 deal advisors
- 1 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| William Harley III | 56 | Chief Executive Officer, Director |
| Paul Wimer | 55 | President and Chief Operating Officer |
| Jeffrey Stegner | 63 | Chief Financial Officer |
| Daniel Harley | 55 | Executive Vice President, Business Development, Director |
| Brendan Sheehan | 49 | Executive Vice President, Corporate Strategy and Investor Relations, Director |
| Steven Cummings | 56 | Director |
| John Falcon | 71 | Chairman |
| Thomas Megale | 60 | Director |
| John Torrance, III | 44 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Imperial Capital | BR | 12,000,000 | units |
| I-Bankers Securities | 3,000,000 | ||
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 4.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.